Effects of phencyclidine on immediate early gene expression in the brain.
Riitta Näkki, FR Sharp, S M Sagar, J Honkaniemi
Journal of Neuroscience Research July 1, 1996 DOI: 10.1002/(sici)1097-4547(19960701)45:1<13::aid-jnr2>3.0.co;2-k (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Rats (animal study) |
| Intervention | Phencyclidine (PCP) |
| Dose | 10 and 50 mg/kg, intraperitoneal |
| Duration | Assessed from 30 minutes to 24 hours after drug treatment |
| Measures | In situ hybridization histochemistry (c-fos, c-jun, egr-2, egr-3, NGFI-A, NGFI-B, NGFI-C, Nurr1) |
| Key findings | PCP at 50 mg/kg produced a biphasic induction of immediate-early genes: an early wave at 30 minutes in hippocampus, cerebral cortex, and cerebellar granule cells, and a delayed wave 2-6 hours later in the posterior cingulate cortex and cerebellar Purkinje cells, the sites of PCP toxicity. A 10 mg/kg dose produced lower expression with a similar pattern but no hippocampal induction. The authors propose that prolonged IEG expression at these sites could mediate neurotoxic or neuroprotective effects. |
Abstract
The N-methyl-D-aspartate receptor antagonist phencyclidine (PCP) is a psychotomimetic drug which produces schizophrenia-like psychosis. In animal studies it is toxic to neurons in the posterior cingulate and retrosplenial cortex and to cerebellar Purkinje cells. To find clues about the mechanism and pathways of PCP action, we studied the effect of systemic PCP administration (10 and 50 mg/kg, intraperitoneal) on the expression of immediate-early genes (IEGs) (c-fos, c-jun, egr-2, egr-3, NGFI-A, NGFI-B, NGFI-C, and Nurr1) using in situ hybridization histochemistry. PCP, 50 mg/kg, produced a biphasic IEG induction: an early induction in the hippocampus, cerebral cortex, and cerebellar granule cell layer, and a delayed induction in the posterior cingulate cortex and cerebellar Purkinje cell layer. The early induction of all eight IEGs was observed 30 min after drug treatment in the cerebral cortex and in the hippocampus. c-fos, NGFI-A, and NGFI-B were also induced in thalamic nuclei, and c-fos was also induced in the cerebellar granule cell layer. In contrast, a delayed induction of c-fos, c-jun, NGFI-A, NGFI-B, NGFI-C, and Nurr1 in the posterior cingulate cortex was observed 2-6 hr after PCP, 50 mg/kg. egr-2 and egr-3 were not induced in the posterior cingulate cortex. c-fos induction in the cerebellar Purkinje cell layer peaked 2 hr after PCP, 50 mg/kg. In addition, PCP induced c-fos, egr-3, NGFI-A, NGFI-B, NGFI-C, and Nurr1 in the inferior olivary nucleus. PCP-induced IEG expression returned to baseline by 24 hr. A lower PCP dose, 10 mg/kg, induced lower levels of IEG expression, with similar anatomical and biphasic temporal pattern as with the higher PCP dose of 50 mg/kg. However, no IEG induction was observed in the hippocampus following 10 mg/kg PCP. These results demonstrate that PCP produces neural activation not only in the cingulate and retrosplenial cortex, but also in many other regions of forebrain and cerebellum. Moreover, prolonged IEG expression in the posterior cingulate cortex and cerebellar Purkinje cells, the sites of PCP toxicity, suggests that IEGs could mediate neurotoxic/neuroprotective effects in these brain regions.
Citations in the library
Cited by 10
- Positive association of phencyclidine-responsive genes, PDE4A and PLAT, with schizophrenia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics December 2011
- Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study. Progress in Neuro-Psychopharmacology and Biological Psychiatry February 15, 2008
- NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophrenia Research January 1, 2005
- The NMDA receptor hypofunction model of psychosis. Annals of the New York Academy of Sciences November 1, 2003
- Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neuroscience and biobehavioral reviews June 2002
and 5 more in the library
Cites 8
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- NMDA Antagonist Neurotoxicity: Mechanism and Prevention Science December 6, 1991
- Cerebellar toxicity of phencyclidine Journal of Neuroscience March 1, 1995
- The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain research. Brain research reviews February 1, 1995
- A rat model of phencyclidine psychosis. Life Sciences 1994
and 3 more in the library